Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: The Medicines Company UK Ltd 115L Milton Park Abingdon Oxfordshire OX14 4SA UNITED KINGDOM
Angiox 250 mg powder for concentrate for solution for injection or infusion.
| Pharmaceutical Form |
|---|
|
Powder for concentrate for solution for injection or infusion. White to off-white lyophilised powder. |
Each vial contains 250 mg bivalirudin.
After reconstitution 1 ml contains 50 mg bivalirudin.
After dilution 1 ml contains 5 mg bivalirudin.
For a full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Bivalirudin |
Bivalirudin is a direct and specific thrombin inhibitor that binds both to the catalytic site and the anion-binding exosite of fluid-phase and clot-bound thrombin. |
| List of Excipients |
|---|
|
Mannitol |
Angiox is supplied as a lyophilised powder in 10 ml single use glass vials (Type 1) closed with a butyl rubber stopper and sealed with a crimped aluminum seal.
Angiox is available in packs of 10 vials.
The Medicines Company UK Ltd
115L Milton Park
Abingdon
Oxfordshire
OX14 4SA
UNITED KINGDOM
EU/1/04/289/001
20.09.2004/20.09.2009
| Drug | Countries | |
|---|---|---|
| ANGIOX | Estonia, Lithuania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
